Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | HPN | P05981 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13400274 | 0.78 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL9241639 | 0.77 | ALDH1A1 (0.42) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL9245454 | 0.77 | CYP2C19 (0.35) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL392804 | 0.76 | SMN1; SMN2 (0.52) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL30448978 | 0.76 | SMN1; SMN2 (0.52) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL1882430 | 0.76 | SMN1; SMN2 (0.52) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL599369 | 0.76 | CYP2C19 (0.47) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29393893 | 0.76 | CYP2C19 (0.47) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL9416923 | 0.74 | CYP2C19 (0.47) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL16106036 | 0.73 | CA2 (0.45) | SMN1; SMN2ALDH1A1CA2POLBTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 849 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106459234-B | Crosslinking control in high-impact polystyrene manufacturing process | 弗纳技术股份有限公司 | 2018-07-06 | — | — | CN | claimed |
| EP-2679623-B1 | Curing agent for epoxy resin systems and their use | EVONIK DEGUSSA GMBH (DE) | 2017-01-11 | — | — | EP | claimed |
| EP-0835282-B1 | IMPROVED PHENOLIC SCORCH RETARDERS | SARTOMER CO INC (US) | 2003-04-09 | — | — | EP | claimed |
| WO-2000066671-A1 | POWDER PAINT COMPOSITION | DSM N.V. (NL) | 2000-11-09 | — | — | WO | claimed |
| US-5696190-A | CURABLE ELASTOMERS MIXED WITH AN ACID SALT OF (DI)ALKYLAMINOALKYL PHENOL | SARTOMER COMPANY (US) | 1997-12-09 | — | — | US | claimed |
| US-20260071010-A1 | RHEOLOGY MODIFYING OF POLYMERS WITH A RADICAL INITIATOR AND THIOURETHANE | BASF SE (DE) | 2026-03-12 | — | — | US | disclosed |
| US-12286380-B2 | Shaped artificial polymer articles | BASF SE (DE) | 2025-04-29 | — | — | US | disclosed |
| US-12274765-B2 | Curable composition for producing a dental composite crown and process of production | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-04-15 | — | — | US | disclosed |
| US-20250114283-A1 | Dental Composition Containing a Resorcinol or Catechol Moiety Containing Component and Use Thereof | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-04-10 | — | — | US | disclosed |
| CN-116507309-B | Dental pH sensitive microcapsules | 舒万诺知识产权公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119587186-A | Preformed composite dental crowns, methods of production and uses thereof | 舒万诺知识产权公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-4124646-B1 | HYDRAULIC FLUID | AFTON CHEMICAL CORP (US) | 2025-01-22 | — | — | EP | disclosed |
| EP-0183642-A1 | Boron containing thioethers as additives | CIBA-GEIGY AG (CH) | 1986-06-04 | — | — | EP | disclosed |
| EP-0166696-A2 | Lubricant additives | CIBA-GEIGY AG (CH) | 1986-01-02 | — | — | EP | disclosed |
| EP-0149422-A2 | Antioxidant preparation | CIBA-GEIGY AG (CH) | 1985-07-24 | — | — | EP | disclosed |
| EP-0113666-A1 | Hydroxybenzylcyclopentadienes and derivatives thereof | The B.F. GOODRICH Company (US) | 1984-07-18 | — | — | EP | disclosed |
| US-4456771-A | Chemical process for preparing 1,3-diketones | ETHYL CORPORATION (US) | 1984-06-26 | — | — | US | disclosed |
| EP-0105772-A2 | Substituted benzyl diketones and process therefor | ETHYL CORPORATION (US) | 1984-04-18 | — | — | EP | disclosed |
| EP-0032008-B1 | LUBRICATING COMPOSITION | EDWIN COOPER & COMPANY LIMITED (GB) | 1983-07-20 | — | — | EP | disclosed |
| EP-0032617-B1 | LUBRICATING COMPOSITION | EDWIN COOPER & COMPANY LIMITED (GB) | 1983-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071010-A1 | RHEOLOGY MODIFYING OF POLYMERS WITH A RADICAL INITIATOR AND THIOURETHANE | NOX1, CBR1, NOS1 | SMN1; SMN2 3017/4885ALDH1A1 1317/4885CA2 926/4885 |
| US-12274765-B2 | Curable composition for producing a dental composite crown and process of production | SEM1, CAD, SMCHD1 | SMN1; SMN2 797/4885ALDH1A1 964/4885CA2 2012/4885 |
| US-20250114283-A1 | Dental Composition Containing a Resorcinol or Catechol Moiety Containing Component and Use Thereof | RDX, RECQL, RABGGTB | SMN1; SMN2 4550/4885ALDH1A1 2001/4885CA2 2904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.